Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19

Individuals with diabetes/stress hyperglycemia carry an increased risk for adverse clinical outcome in case of SARS-CoV-2 infection. The purpose of this study was to evaluate whether this risk is, at least in part, modulated by an increase of thromboembolic complications.

Source: Metabolism - Clinical and Experimental - August 5, 2021 Category: Biomedical Science Authors: Stefania L. Calvisi, Giuseppe A. Ramirez, Marina Scavini, Valentina Da Prat, Giuseppe Di Lucca, Andrea Laurenzi, Gabriele Gallina, Ludovica Cavallo, Giorgia Borio, Federica Farolfi, Maria Pascali, Jacopo Castellani, Vito Lampasona, Armando D'Angelo, Giova Source Type: research